Lixte Biotechnology, Inc.
🏢 View company profile →27Patents
27Active
27Granted
49Portfolio score
Filing activity: Feb 6, 2008 → Jun 16, 2023 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8058268B2 | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases | Human Necessities | 33 | Active |
| US7998957B2 | Oxabicycloheptanes and oxabicylcoheptenes, their preparation and use | Human Necessities | 25 | Active |
| US8227473B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Chemistry; Metallurgy | 23 | Active |
| US8143445B2 | HDAC inhibitors | Human Necessities | 18 | Active |
| US8426444B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Human Necessities | 16 | Active |
| US9079917B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Human Necessities | 16 | Active |
| US8541458B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Chemistry; Metallurgy | 16 | Active |
| US8329719B2 | Neuroprotective agents for the prevention and treatment of neurodegenerative diseases | Human Necessities | 16 | Active |
| US8822461B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Human Necessities | 15 | Active |
| US8455688B2 | HDAC inhibitors | Human Necessities | 14 | Active |
| US9833450B2 | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | Chemistry; Metallurgy | 9 | Active |
| US9994584B2 | Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid | Chemistry; Metallurgy | 6 | Active |
| US10364252B2 | Oxabicycloheptane prodrugs | Chemistry; Metallurgy | 6 | Active |
| US10149847B2 | Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes | Chemistry; Metallurgy | 6 | Active |
| US10023587B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Human Necessities | 6 | Active |
| US9988394B2 | Oxabicycloheptane prodrugs | Chemistry; Metallurgy | 6 | Active |
| US10532050B2 | Formulations of oxabicycloheptanes and oxabicycloheptenes | Human Necessities | 5 | Active |
| US10618908B2 | Oxabicycloheptane prodrugs | Chemistry; Metallurgy | 5 | Active |
| US10434100B2 | Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes | Human Necessities | 5 | Active |
| US10399993B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Human Necessities | 5 | Active |
| US10413541B2 | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | Chemistry; Metallurgy | 5 | Active |
| US10668062B2 | Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes | Chemistry; Metallurgy | 5 | Active |
| US11236102B2 | Oxabicycloheptane prodrugs | Chemistry; Metallurgy | 4 | Active |
| US11931354B2 | Formulations of oxabicycloheptanes and oxabicycloheptenes | Human Necessities | 1 | Active |
| US11866444B2 | Oxabicycloheptane prodrugs | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.